Sat.Jan 25, 2020 - Fri.Jan 31, 2020

article thumbnail

Rapid Nonclinical Planning and Coordination Keep Post-Marketing Requirements on Track

Camargo

After a biotech company received paper NDA approval for their drug, Camargo contributed to successful commercialization, planning and executing Phase 4 post-marketing requirements with a short timeline. The post Rapid Nonclinical Planning and Coordination Keep Post-Marketing Requirements on Track appeared first on Camargo.

Marketing 130
article thumbnail

New antiviral materials made from sugar have been developed to destroy viruses on contact and may help in the fight against viral outbreaks.

Drug Discovery Today

This new development from a collaborative team of international scientists shows promise for the treatment of herpes simplex (cold sore virus), respiratory syncytial virus, hepatitis C, HIV, and Zika virus to name a few. The team have demonstrated success treating a range of viruses in the lab – including respiratory infections to genital herpes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Your Fancy Degree Means Nothing In Clinical Research

ECRG Media's Clinical Research Podcast

Your Fancy Degree Means Nothing In Clinical Research Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education

article thumbnail

Celebrating 25 Years of Pharmaceutical Packaging Experience

Pharma Packaging Solutions

Happy 2020! There is something about a new decade that brings a sharper focus on the future. At Pharma Packaging Solutions, we are celebrating 25 years of pharmaceutical packaging experience and now we look forward to the next 25 years. Our 1995 facility addition in East Tennessee and focus on pharmaceutical packaging has been a journey through myriad technical challenges, a learning curve through regulatory change, and a pleasure through many customer success stories.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Real World Evidence Saves Project

Camargo

When a biotech company could not afford the time and expense to conduct intended studies, we stepped in and quickly and creatively turned things around with the FDA. The post Real World Evidence Saves Project appeared first on Camargo.

130
130
article thumbnail

UK withdrawal from the EU on 31 January 2020

Drug Discovery Today

The United Kingdom will formally leave the European Union on 31 January 2020 and will become a third country to the EU. On 1 February 2020 a transition period will start which is due to end on 31 December 2020.

40

More Trending

article thumbnail

Shkreli is sued for monopolizing Daraprim. But what ever happened to Azar’s single source drug import plan?

Pharmacy Checkers

Martin Shkreli, who became famous overnight back in 2015 for raising the price of Daraprim 5000%, is back in the headlines. Tagged the “pharma bro” for the cavalier attitude he fronted about his greed, Martin is actually currently behind bars. No, not for raising a drug price – otherwise the jails would overflow with pharma execs – but for financial fraud related to his work as hedge fund manager.

Drugs 54
article thumbnail

Strategic Submission Preparation Redefines Product Value

Camargo

With strategic submission support, a biotech company gained approval for an improved delivery technology of an already-approved drug, setting the potential to become a new “gold standard” treatment in oncology. The post Strategic Submission Preparation Redefines Product Value appeared first on Camargo.

article thumbnail

Stopping sperm in its tracks - latest progress in the hunt for a male contraceptive

Drug Discovery Today

Researchers at the University of Dundee have developed an unrivalled, fully automated robotic screening system which allows them to rapidly test the effect of drugs and other chemicals on human sperm.

article thumbnail

Combination Product Expertise and Target Market Knowledge Create Commercial Success

Camargo

By identifying the proper product category, we worked with an international company to correctly reposition its drug-device combination product for FDA approval and drive market penetration. The post Combination Product Expertise and Target Market Knowledge Create Commercial Success appeared first on Camargo.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Nasal spray medicine for treatment-resistant depression not recommended by NICE

Drug Discovery Today

A nasal spray for treatment-resistant depression has not been recommended by NICE because of uncertainties over its clinical and cost effectiveness.

article thumbnail

Pinpointing rare disease mutations

Drug Discovery Today

New resource that categorises genes essential for supporting life could be used to identify rare disease mutations

Gene 40